Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R (2017) Epidemiology of uterine fibroids: a systematic review. BJOG 124(10):1501–1512
Article CAS PubMed Google Scholar
Laughlin SK, Stewart EA (2011) Uterine leiomyomas: individualizing the approach to a heterogeneous condition. Obstet Gynecol 117(2 Pt 1):396–403
Article PubMed PubMed Central Google Scholar
Pritts EA, Parker WH, Olive DL (2009) Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril 91(4):1215–1223
Ravina JH, Merland JJ, Ciraru-Vigneron N, Bouret JM, Herbreteau D, Houdart E, et al (1995) Arterial embolization: a new treatment of menorrhagia in uterine fibroma. vol 24, Presse medicale (Paris, France : 1983). France, pp 1754
Hehenkamp WJK, Volkers NA, Donderwinkel PFJ, De Blok S, Birnie E, Ankum WM et al (2005) Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): peri- and postprocedural results from a randomized controlled trial. Am J Obstet Gynecol 193(5):1618–1629
de Bruijn AM, Ankum WM, Reekers JA, Birnie E, van der Kooij SM, Volkers NA et al (2016) Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial. Am J Obstet Gynecol 215(6):745.e1-745.e12
Manyonda IT, Bratby M, Horst JS, Banu N, Gorti M, Belli AM (2012) Uterine artery embolization versus myomectomy: impact on quality of life–results of the FUME (fibroids of the uterus: myomectomy versus embolization) trial. Cardiovasc Intervent Radiol 35(3):530–536
Moss JG, Cooper KG, Khaund A, Murray LS, Murray GD, Wu O et al (2011) Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. BJOG 118(8):936–944
Article CAS PubMed Google Scholar
Das R, Champaneria R, Daniels JP, Belli AM (2014) Comparison of embolic agents used in uterine artery embolisation: a systematic review and meta-analysis. Cardiovasc Intervent Radiol 37(5):1179–1190
Yu SCH, Lok I, Ho SSY, Tong MMB, Hui JWY (2011) Comparison of clinical outcomes of tris-acryl microspheres versus polyvinyl alcohol microspheres for uterine artery embolization for leiomyomas: results of a randomized trial. J Vasc Interv Radiol 22(9):1229–1235
Worthington-Kirsch RL, Hughes LA (2003) Uterine artery embolization—vascular anatomic considerations and procedure techniques. Uterine Fibroids 11:83–90
Katsumori T, Kasahara T, Kin Y, Nozaki T (2008) Infarction of uterine fibroids after embolization: relationship between postprocedural enhanced MRI findings and long-term clinical outcomes. Cardiovasc Intervent Radiol 31(1):66–72
Patetta MA, Isaacson AJ, Stewart JK (2021) Initial experience with HydroPearl microspheres for uterine artery embolization for the treatment of symptomatic uterine fibroids. CVIR Endovasc. https://doi.org/10.1186/s42155-021-00223-9
Article PubMed PubMed Central Google Scholar
Noda Y, Kanematsu M, Goshima S, Kondo H, Watanabe H, Kawada H et al (2015) Prediction of early response to uterine artery embolization in fibroids: value of MR signal intensity ratio. Magn Reson Imaging 33(1):51–55
Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM (2002) The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol 99(2):290–300
Kroencke TJ, Scheurig C, Poellinger A, Gronewold M, Hamm B (2010) Uterine artery embolization for leiomyomas: percentage of infarction predicts clinical outcome. Radiology 255(3):834–841
Duvnjak S, Ravn P, Green A, Andersen PE (2017) Uterine fibroid embolization with acrylamido polyvinyl microspheres: prospective 12-month clinical and MRI follow-up study. Acta Radiol 58(8):952–958
Martin J, Bhanot K, Athreya S (2013) Complications and reinterventions in uterine artery embolization for symptomatic uterine fibroids: a literature review and meta analysis. Cardiovasc Intervent Radiol 36(2):395–402
Nikolic B, Nguyen K, Martin LG, Redd DCM, Best I, Silverstein MI (2004) Pyosalpinx developing from a preexisting hydrosalpinx after uterine artery embolization. J Vasc Interv Radiol 15(3):297–301
Petruzzi NJ, McCann JW, Patel NA, Gonsalves CF (2012) Safety of uterine artery embolization in patients with preexisting hydrosalpinx. J Vasc Interv Radiol 23(6):796–799
Di Stasi C, Cina A, Rosella F, Paladini A, Amoroso S, Romualdi D et al (2018) Uterine fibroid embolization efficacy and safety: 15 years experience in an elevated turnout rate center. Radiol Med 123(5):385–397
Lohle PNM, Boekkooi FP, Smeets AJ, Pieters JJPM, Vervest HAM, Lampmann LEH et al (2006) Limited uterine artery embolization for leiomyomas with tris-acryl gelatin microspheres: 1-year follow-up. J Vasc Interv Radiol 17(2 Pt 1):283–287
Salehi M, Jalilian N, Salehi A, Ayazi M (2015) Clinical efficacy and complications of uterine artery embolization in symptomatic uterine fibroids. Glob J Health Sci 8(7):245–250
Article PubMed PubMed Central Google Scholar
Joffre F, Tubiana JM, Pelage JP (2004) FEMIC (fibromes embolisés aux microsphères calibrées): uterine fibroid embolization using tris-acryl microspheres. A French multicenter study. Cardiovasc Intervent Radiol 27(6):600
Toda A, Sawada K, Osuga K, Maeda N, Higashihara H, Sasano T et al (2016) Efficacies of uterine artery embolization for symptomatic uterine fibroids using gelatin sponge: a single-center experience and literature review. Int J Womens Health 12(8):397–404
Stampfl U, Radeleff B, Sommer C, Stampfl S, Dahlke A, Bellemann N et al (2011) Midterm results of uterine artery embolization using narrow-size calibrated embozene microspheres. Cardiovasc Intervent Radiol 34(2):295–305
Spies JB, Allison S, Flick P, Cramp M, Bruno J, Jha RC et al (2005) Spherical polyvinyl alcohol versus tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: results of a limited randomized comparative study. J Vasc Interv Radiol 16(11):1431–1437
Siskin GP, Beck A, Schuster M, Mandato K, Englander M, Herr A (2008) Leiomyoma infarction after uterine artery embolization: a prospective randomized study comparing tris-acryl gelatin microspheres versus polyvinyl alcohol microspheres. J Vasc Interv Radiol 19(1):58–65
Katsumori T, Kasahara T, Tsuchida Y, Nozaki T (2008) Amenorrhea and resumption of menstruation after uterine artery embolization for fibroids. Int J Gynaecol Obstet 103(3):217–221
Chrisman HB, Saker MB, Ryu RK, Nemcek AA, Gerbie MV, Milad MP et al (2000) The impact of uterine fibroid embolization on resumption of menses and ovarian function. J Vasc Interv Radiol 11(6):699–703
Article CAS PubMed Google Scholar
Ghanaati H, Sanaati M, Shakiba M, Bakhshandeh H, Ghavami N, Aro S et al (2020) Pregnancy and its outcomes in patients after uterine fibroid embolization: a systematic review and meta-analysis. Cardiovasc Intervent Radiol 43(8):1122–1133
Katsumori T, Miura H, Yoshikawa T, Seri S, Kotera Y, Asato A (2020) Intra-arterial lidocaine administration for anesthesia after uterine artery embolization with trisacryl gelatin microspheres for leiomyoma. J Vasc Interv Radiol 31(1):114–120
Davis MR, Soliman AM, Castelli-Haley J, Snabes MC, Surrey ES (2018) Reintervention rates after myomectomy, endometrial ablation, and uterine artery embolization for patients with uterine fibroids. J Womens Health (Larchmt) 27(10):1204–1214
Yoon JK, Han K, Kim MD, Kim GM, Kwon JH, Won JY et al (2018) Five-year clinical outcomes of uterine artery embolization for symptomatic leiomyomas: an analysis of risk factors for reintervention. Eur J Radiol 1(109):83–87
留言 (0)